Bain Capital Public Equity Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bain Capital Public Equity Management’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-1,147,833	Closed	-$11.6M	–	62
2014 Q2	$11.6M	Hold	1,147,833	–	–	0.28%	54
2014 Q1	$15.4M	Buy	+1,147,833	New	+$16.2M	0.41%	43

Other funds holding CNCE

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.35% 1-Year Est. Return

Bain Capital Public Equity Management's CNCE Position: Q3 2014 in Review

Bain Capital Public Equity Management sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q3 2014, closing a stake of 1,147,833 shares — an estimated $11.6M sold.

Bain Capital Public Equity Management first reported a position in CNCE in Q1 2014 and held it in 2 quarters. The position peaked at $15.4M in Q1 2014. 51 funds tracked by Wall St. Rank hold CNCE as of Q3 2014.

Bain Capital Public Equity Management reported no remaining Concert Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
Bain Capital Public Equity Management sold 1,147,833 Concert Pharmaceuticals, Inc. shares in Q3 2014, an estimated $11.6M.
Bain Capital Public Equity Management first reported a position in Concert Pharmaceuticals, Inc. in Q1 2014 and held it in 2 quarters.
Bain Capital Public Equity Management's Concert Pharmaceuticals, Inc. position peaked at $15.4M in Q1 2014.
51 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q3 2014.

Based on Bain Capital Public Equity Management's 13F filing for Q3 2014, filed 14 Nov 2014.